Shares of Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) dropped 4% during mid-day trading on Friday . The company traded as low as $1.44 and last traded at $1.44. 100 shares were traded during mid-day trading, a decline of 96% from the average session volume of 2,831 shares. The stock had previously closed at $1.50.
Ascletis Pharma Stock Performance
The firm has a 50 day simple moving average of $1.61 and a two-hundred day simple moving average of $1.79.
Ascletis Pharma Company Profile
Ascletis Pharma (OTCMKTS:ASCLF) is a clinical?stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small?molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.
The company’s core pipeline focuses on direct?acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
Read More
- Five stocks we like better than Ascletis Pharma
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
- Micron’s $250 Billion Bet Could Reshape the AI Memory Race
- Rocket Lab’s Stock Drop Comes With a Bullish Twist
- Amazon’s New Debt Deal Puts Its AI Spending Story on Trial
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
